- Price
- $13.60
- Day
- +5.67%
- Mkt Cap
- $333.26M
- 52W Range
- $9.28 – $45.00
- Volume
- 186.7K
- Beta
- -0.07
Find a company by name or ticker and open its page
Breaking news, press releases, and analyst updates.
Most recent articles and analysis covering this company.
Lyell Immunopharma, Inc. (NASDAQ: LYEL - Get Free Report) has received an average rating of "Moderate Buy" from the seven ratings firms that are currently covering the firm, Marketbeat.com reports. One analyst has rated the stock with a sell recommendation, one has given a hold recommendation, four have assigned a buy recommendation and one has issued
Read full article